Updated Jul 16, 2026
Longcor Jarrod has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $75K.
Jarrod Longcor is the Chief Operating Officer of Cellectar Biosciences, Inc., a clinical-stage biopharmaceutical company focused on cancer treatment. He has been involved in the company's operations but does not appear to have significant public recognition outside of his role.
| Role | Chief Operating Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | CLRB | Cellectar Biosciences, Inc. | P — Open-market purchase | 8.7K | $2.88 | $25K |
| 2025-07-02 | CLRB | Cellectar Biosciences, Inc. | P — Open-market purchase | 10.0K | $4.99 | $50K |
Jarrod Longcor is the Chief Operating Officer of Cellectar Biosciences, Inc., a clinical-stage biopharmaceutical company focused on cancer treatment. He has been involved in the company's operations but does not appear to have significant public recognition outside of his role.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($75K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Longcor Jarrod profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.